154 related articles for article (PubMed ID: 27056836)
21. Structural Basis for a Species-Specific Determinant of an SIV Vif Protein toward Hominid APOBEC3G Antagonism.
Binning JM; Chesarino NM; Emerman M; Gross JD
Cell Host Microbe; 2019 Dec; 26(6):739-747.e4. PubMed ID: 31830442
[TBL] [Abstract][Full Text] [Related]
22. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
Langlois MA; Beale RC; Conticello SG; Neuberger MS
Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
[TBL] [Abstract][Full Text] [Related]
23. Evidence for widespread degradation of gene control regions in hominid genomes.
Keightley PD; Lercher MJ; Eyre-Walker A
PLoS Biol; 2005 Feb; 3(2):e42. PubMed ID: 15678168
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
25. Neurogenomics and the role of a large mutational target on rapid behavioral change.
Stanley CE; Kulathinal RJ
Biol Direct; 2016 Nov; 11(1):60. PubMed ID: 27825385
[TBL] [Abstract][Full Text] [Related]
26. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.
Rogozin IB; Roche-Lima A; Lada AG; Belinky F; Sidorenko IA; Glazko GV; Babenko VN; Cooper DN; Pavlov YI
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30759888
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
28. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
[TBL] [Abstract][Full Text] [Related]
30. Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.
Köck J; Blum HE
J Gen Virol; 2008 May; 89(Pt 5):1184-1191. PubMed ID: 18420796
[TBL] [Abstract][Full Text] [Related]
31. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
32. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
[TBL] [Abstract][Full Text] [Related]
33. The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
Haché G; Liddament MT; Harris RS
J Biol Chem; 2005 Mar; 280(12):10920-4. PubMed ID: 15647250
[TBL] [Abstract][Full Text] [Related]
34. The importance of codon context for understanding the Ig-like somatic hypermutation strand-biased patterns in TP53 mutations in breast cancer.
Lindley RA
Cancer Genet; 2013 Jun; 206(6):222-6. PubMed ID: 23880211
[TBL] [Abstract][Full Text] [Related]
35. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
36. High genomic deleterious mutation rates in hominids.
Eyre-Walker A; Keightley PD
Nature; 1999 Jan; 397(6717):344-7. PubMed ID: 9950425
[TBL] [Abstract][Full Text] [Related]
37. [Recent advances in the study of mechanism of APOBEC3G against virus].
Zhu YP; Jiang JD; Peng ZG
Yao Xue Xue Bao; 2014 Jan; 49(1):30-6. PubMed ID: 24783502
[TBL] [Abstract][Full Text] [Related]
38. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional assessment of APOBEC3G macromolecular complexes.
Polevoda B; McDougall WM; Bennett RP; Salter JD; Smith HC
Methods; 2016 Sep; 107():10-22. PubMed ID: 26988126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
